Jones Financial Companies Lllp Akebia Therapeutics, Inc. Transaction History
Jones Financial Companies Lllp
- $105 Billion
- Q4 2024
A detailed history of Jones Financial Companies Lllp transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Jones Financial Companies Lllp holds 1,000 shares of AKBA stock, worth $2,080. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000
Previous 1,000
-0.0%
Holding current value
$2,080
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding AKBA
# of Institutions
127Shares Held
57.4MCall Options Held
291KPut Options Held
179K-
Black Rock Inc. New York, NY11.6MShares$24.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$22.6 Million0.0% of portfolio
-
State Street Corp Boston, MA6.3MShares$13.1 Million0.0% of portfolio
-
Satter Management Co., L.P.5.75MShares$12 Million13.23% of portfolio
-
Geode Capital Management, LLC Boston, MA4.8MShares$9.97 Million0.0% of portfolio
About Akebia Therapeutics, Inc.
- Ticker AKBA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 183,848,992
- Market Cap $382M
- Description
- Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...